Dashboard
Manage Tickers

PFEPFIZER INC

NYSE pfizer.com


$ 27.99 $ -0.37 (-1.3 %)    

Tuesday, 25-Jun-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 27.99
$ 28.34
$ 0.00 x 0
$ 28.00 x 300
$ 27.94 - $ 28.41
$ 24.83 - $ 35.80
24,703,645
na
159.46B
$ 0.57
nm
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-08-2023 10-01-2023 10-Q
4 08-09-2023 07-02-2023 10-Q
5 05-10-2023 04-02-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-09-2022 10-02-2022 10-Q
8 08-10-2022 07-03-2022 10-Q
9 05-11-2022 04-03-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-12-2021 10-03-2021 10-Q
12 08-12-2021 07-04-2021 10-Q
13 05-13-2021 04-04-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-27-2020 10-Q
16 08-06-2020 06-28-2020 10-Q
17 05-07-2020 03-29-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-07-2019 09-29-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 07-01-2018 10-Q
25 05-10-2018 04-01-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 11-09-2017 10-01-2017 10-Q
28 08-10-2017 07-02-2017 10-Q
29 05-11-2017 04-02-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-10-2016 10-02-2016 10-Q
32 08-11-2016 07-03-2016 10-Q
33 05-12-2016 04-03-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-05-2015 09-27-2015 10-Q
36 08-06-2015 06-28-2015 10-Q
37 05-07-2015 03-29-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-06-2014 09-28-2014 10-Q
40 08-07-2014 06-29-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
06/25/2024 17:35:24

supreme-court-backs-pharmaceutical-giants-in-iraq-terrorism-funding-case
Supreme Court Backs Pharmaceutical Giants ...
06/24/2024 19:47:37

The U.S. Supreme Court supports pharmaceutical companies, led by AstraZeneca, in a lawsuit accusing them of funding terrorism i...

uk-chooses-pfizer-over-gsk-for-multi-million-dose-rsv-vaccine-contract
UK Chooses Pfizer Over GSK for Multi-Milli...
06/24/2024 15:35:12

Pfizer secures a UK contract to supply millions of doses of its Abrysvo RSV vaccine, surpassing GSK's bid. The agreement in...

Core News & Articles
'UK Government Snubs GSK in Favor of Pfize...
06/24/2024 12:00:37

GSK Plc has lost out to Pfizer Inc. on a contract to supply millions of doses of its blockbuster RSV vaccine to the UK in a set...

gilead-sciences-faces-wall-street-speculation-about-obesity-drugs-despite-focus-on-liver-treatments
Gilead Sciences Faces Wall Street Speculat...
06/21/2024 15:42:22

Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatme...

fda-approves-expanded-use-for-sareptas-rare-muscular-dystrophy-gene-therapy
FDA Approves Expanded Use For Sarepta's Ra...
06/21/2024 11:39:52

The FDA has approved Sarepta Therapeutics' Elevidys for treating Duchenne muscular dystrophy in patients aged 4 and older w...

industry-groups-back-gsks-effort-to-halt-70000-lawsuits-associated-with-heartburn-drug-zantac-caused-cancer
Industry Groups Back GSK's Effort To Halt ...
06/20/2024 18:03:20

GSK, supported by major industry groups, seeks to stop 70,000 Zantac lawsuits in Delaware, arguing a recent court ruling threat...

cantor-fitzgerald-reiterates-overweight-on-pfizer-maintains-45-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/20/2024 17:04:06

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

supreme-court-upholds-2017-tax-on-foreign-profits-for-us-businesses
Supreme Court Upholds 2017 Tax On Foreign ...
06/20/2024 16:14:06

US Supreme Court upholds 2017 tax on foreign business income, citing Congress' constitutional power to tax. Justices Kavana...

palantir-oracle-pfizer-chiefs-lobby-us-lawmakers-for-israels-support-amid-hamas-attack-hostage-crisis
Palantir, Oracle, Pfizer Chiefs Lobby US L...
06/19/2024 08:14:35

CEOs of Palantir, Oracle, and Pfizer lobbied US senators for support of Israel during Gaza invasion and discussed solutions for...

covid-19-pharma-stars-continue-their-quest-to-set-new-standards-in-cancer-treatment
Covid-19 Pharma Stars Continue Their Quest...
06/18/2024 14:19:12

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its bloc...

fda-approves-mercks-pneumococcal-vaccine-as-first-shot-designed-for-adults
FDA Approves Merck's Pneumococcal Vaccine ...
06/18/2024 12:05:42

The FDA has approved Merck's Capvaxive, the first pneumococcal conjugate vaccine for adults, protecting against 21 strains ...

cantor-fitzgerald-reiterates-overweight-on-pfizer-maintains-45-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/17/2024 17:32:42

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

pfizers-covid-19-vaccine-safety-claims-under-lens-faces-lawsuit-from-kansas-for-alleged-misleading-claims
Pfizer's COVID-19 Vaccine Safety Claims Un...
06/17/2024 17:13:42

Kansas has filed a lawsuit against Pfizer, Inc., alleging the company misled the public about the safety and effectiveness of i...

kansas-sues-pfizer-over-misrepresentations-and-adverse-affects-of-covid-19-vaccine---fox-business
'Kansas sues Pfizer over 'misrepresentatio...
06/17/2024 15:28:21

https://www.foxbusiness.com/politics/kansas-sues-pfizer-over-misrepresentations-adverse-affects-covid-19-vaccine

Core News & Articles
FDA On June 13 Updates Advice To Manufactu...
06/14/2024 18:13:02

- Reuters

how-is-the-market-feeling-about-pfizer
How Is The Market Feeling About Pfizer?
06/14/2024 16:00:15

pfizers-elrexfio-shows-median-overall-survival-of-more-than-two-years-in-phase-2-magnetismm-3-study
Pfizer's ELREXFIO Shows Median Overall Sur...
06/14/2024 07:54:16

Patients in MagnetisMM-3 demonstrated a median overall survival (OS) of 24.6 months, with median progression-free survival (P...

whats-going-on-with-pfizer-on-thursday-pharma-giants-shares-tick-lower
What's Going On With Pfizer On Thursday? P...
06/13/2024 13:18:14

Pfizer Inc. reported that its Phase 3 CIFFREO study on Duchenne muscular dystrophy (DMD) gene therapy did not meet its primary ...

pfizer-says-key-secondary-endpoints-in-phase-3-study-of-investigational-gene-therapy-did-not-show-significant-difference-between-participants-treated-with-fordadistrogene-movaparvovec-and-placebo
Pfizer Says Key Secondary Endpoints In Pha...
06/12/2024 20:33:00

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)